Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

od Mueck, Wolfgang, Kubitza, Dagmar, Becka, Michael
Wydane 2013

The discovery of rivaroxaban: translating preclinical assessments into clinical practice

od Kubitza, Dagmar, Perzborn, Elisabeth, Berkowitz, Scott D.
Wydane 2013

Evidence-Based Development and Rationale for Once-Daily Rivaroxaban Dosing Regimens Across Multiple Indications

od Kubitza, Dagmar, Berkowitz, Scott D., Misselwitz, Frank
Wydane w Clin Appl Thromb Hemost (2016)

Rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxen

od Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Zuehlsdorf, Michael
Wydane 2007

Effect of Co-Administration of Rivaroxaban and Clopidogrel on Bleeding Time, Pharmacodynamics and Pharmacokinetics: A Phase I Study

od Kubitza, Dagmar, Becka, Michael, Mück, Wolfgang, Schwers, Stephan
Wydane 2012

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

od Mueck, Wolfgang, Stampfuss, Jan, Kubitza, Dagmar, Becka, Michael
Wydane 2013

Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects

od Kubitza, Dagmar, Becka, Michael, Mück, Wolfgang, Krätzschmar, Jöern
Wydane 2014

Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

od Siegmund, Hans-Ulrich, Burghaus, Rolf, Kubitza, Dagmar, Coboeken, Katrin
Wydane w Br J Clin Pharmacol (2015)

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor

od Kubitza, Dagmar, Roth, Angelika, Becka, Michael, Alatrach, Abir, Halabi, Atef, Hinrichsen, Holger, Mueck, Wolfgang
Wydane 2013

Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations

od Willmann, Stefan, Zhang, Liping, Frede, Matthias, Kubitza, Dagmar, Mueck, Wolfgang, Schmidt, Stephan, Solms, Alexander, Yan, Xiaoyu, Garmann, Dirk
Wydane w CPT Pharmacometrics Syst Pharmacol (2018)

Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects

od Zhao, Xia, Sun, Peihong, Zhou, Ying, Liu, Yuwang, Zhang, Huilin, Mueck, Wolfgang, Kubitza, Dagmar, Bauer, Richard J, Zhang, Hong, Cui, Yimin
Wydane 2009

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

od Kubitza, Dagmar, Becka, Michael, Mueck, Wolfgang, Halabi, Atef, Maatouk, Haidar, Klause, Norbert, Lufft, Volkmar, Wand, Dominic D, Philipp, Thomas, Bruck, Heike
Wydane 2010

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

od Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
Wydane w Thromb J (2014)

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study

od Willmann, Stefan, Thelen, Kirstin, Kubitza, Dagmar, Lensing, Anthonie W. A., Frede, Matthias, Coboeken, Katrin, Stampfuss, Jan, Burghaus, Rolf, Mück, Wolfgang, Lippert, Jörg
Wydane w Thromb J (2018)

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling

od Solms, Alexander, Frede, Matthias, Berkowitz, Scott D., Hermanowski‐Vosatka, Anne, Kubitza, Dagmar, Mueck, Wolfgang, Spiro, Theodore E., Willmann, Stefan, Yan, Xiaoyu, Zhang, Liping, Garmann, Dirk
Wydane w CPT Pharmacometrics Syst Pharmacol (2019)

Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study

od Kubitza, Dagmar, Willmann, Stefan, Becka, Michael, Thelen, Kirstin, Young, Guy, Brandão, Leonardo R., Monagle, Paul, Male, Christoph, Chan, Anthony, Kennet, Gili, Martinelli, Ida, Saracco, Paola, Lensing, Anthonie W. A.
Wydane w Thromb J (2018)

Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study

od Lensing, Anthonie W. A., Male, Christoph, Young, Guy, Kubitza, Dagmar, Kenet, Gili, Patricia Massicotte, M., Chan, Anthony, Molinari, Angelo C., Nowak-Goettl, Ulrike, Pap, Ákos F., Adalbo, Ivet, Smith, William T., Mason, Amy, Thelen, Kirstin, Berkowitz, Scott D., Crowther, Mark, Schmidt, Stephan, Price, Victoria, Prins, Martin H., Monagle, Paul
Wydane w Thromb J (2018)

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis

od Chan, Anthony, Lensing, Anthonie W. A., Kubitza, Dagmar, Brown, Grahaem, Elorza, Dolores, Ybarra, Marta, Halton, Jacqueline, Grunt, Sebastian, Kenet, Gili, Bonnet, Damien, Santamaria, Amparo, Saracco, Paola, Biss, Tina, Climent, Francesco, Connor, Philip, Palumbo, Joseph, Thelen, Kirstin, Smith, William T., Mason, Amy, Adalbo, Ivet, Berkowitz, Scott D., Hurst, Eva, van Kesteren, Jeroen, Young, Guy, Monagle, Paul
Wydane w Thromb J (2018)

Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)

od Thom, Katharina, Lensing, Anthonie W. A., Nurmeev, Ildar, Bajolle, Fanny, Bonnet, Damien, Kenet, Gili, Massicotte, M. Patricia, Karakas, Zeynep, Palumbo, Joseph S., Saracco, Paola, Amedro, Pascal, Chain, Juan, Chan, Anthony K., Ikeyama, Takanari, Lam, Joyce C. M., Gauger, Cynthia, Pap, Ákos Ferenc, Majumder, Madhurima, Kubitza, Dagmar, Smith, William T., Berkowitz, Scott D., Prins, Martin H., Monagle, Paul, Young, Guy, Male, Christoph
Wydane w Blood Adv (2020)

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

od Connor, Philip, Sánchez van Kammen, Mayte, Lensing, Anthonie W. A., Chalmers, Elizabeth, Kállay, Krisztián, Hege, Kerry, Simioni, Paolo, Biss, Tina, Bajolle, Fanny, Bonnet, Damien, Grunt, Sebastian, Kumar, Riten, Lvova, Olga, Bhat, Rukhmi, Van Damme, An, Palumbo, Joseph, Santamaria, Amparo, Saracco, Paola, Payne, Jeanette, Baird, Susan, Godder, Kamar, Labarque, Veerle, Male, Christoph, Martinelli, Ida, Morales Soto, Michelle, Motwani, Jayashree, Shah, Sanjay, Hooimeijer, Helene L., Prins, Martin H., Kubitza, Dagmar, Smith, William T., Berkowitz, Scott D., Pap, Akos F., Majumder, Madhurima, Monagle, Paul, Coutinho, Jonathan M.
Wydane w Blood Adv (2020)